Antibody producing non-human animals
AssigneeMerus N.V.
InventorsTon Logtenberg, Mark Throsby, Robert A. Kramer, Rui D. Pinto, Cornelis A. De Kruif, Erwin Houtzager
Life of this patent
Estimating the term…
Abstract
Described are transgenic, non-human animals comprising a nucleic acid encoding an immunoglobulin light chain, whereby the immunoglobulin light chain is human, human-like, or humanized. The nucleic acid is provided with a means that renders it resistant to DNA rearrangements and/or somatic hypermutations. In one embodiment, the nucleic acid comprises an expression cassette for the expression of a desired molecule in cells during a certain stage of development in cells developing into mature B cells. Further provided is methods for producing an immunoglobulin from the transgenic, non-human animal.
Claims7
A transgenic mouse that has been immunized to generate an immune response against an antigen, wherein the genome of said mouse comprises a transgene encoding a rearranged immunoglobulin light chain variable region,
- wherein the transgene comprises a single human immunoglobulin light chain V gene segment fused to a single human immunoglobulin light chain J gene segment, wherein the transgene lacks a regulatory element that contributes to somatic hypermutation of the light chain variable region, and wherein said rearranged immunoglobulin light chain variable region is linked to an endogenous immunoglobulin light chain constant region gene segment, and
- wherein said transgenic mouse comprises a population of B cells that secrete a repertoire of antibodies that bind said antigen, said repertoire of antibodies comprising the immunoglobulin light chain variable region encoded by said transgene and further comprising a counterpart heavy chain variable region resulting from somatic hypermutation in response to said antigen.
A transgenic murine animal that has been immunized to generate an immune response against an antigen, wherein the genome of said animal comprises a transgene encoding a rearranged immunoglobulin light chain variable region,
- wherein the transgene comprises a single human immunoglobulin light chain V gene segment fused to a single human immunoglobulin light chain J gene segment, wherein the transgene lacks a regulatory element that contributes to somatic hypermutation of the light chain variable region, and wherein the transgene comprises a nucleic acid sequence encoding an immunoglobulin light chain constant region, and
- wherein said transgenic animal comprises a population of B cells that secrete a repertoire of antibodies that bind said antigen, said repertoire of antibodies comprising the immunoglobulin light chain variable region encoded by said transgene and further comprising a counterpart heavy chain variable region resulting from somatic hypermutation in response to said antigen.
Dependencies are inferred from the claim text.